Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 Years
Conditions: Influenza; Flu Interventions: Biological: SP Shz TIV; Biological: Hualan TIV Sponsor: Sanofi Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials